Join to access to all OVN content. Join for Free
Advancing Cancer Survivorship and Cardio-Oncology
City of Hope Academic Research pediatric

Advancing Cancer Survivorship and Cardio-Oncology


Share This Article



Summary

Dr. Saro Armenian discusses breakthroughs in cancer survivorship, pediatric oncology and City of Hope’s pioneering work in cardio-oncology.

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal is joined by Dr. Saro Armenian, Chair of Pediatric Oncology at City of Hope, to discuss the latest innovative research driving advancements in cancer survivorship and cardio-oncology.

Dr. Armenian shares his compelling journey into oncology, the challenges of addressing long-term treatment effects on patients, and the promising future of CHIP clinics and de-escalation of therapy. Learn how world-leading oncologists are shaping the future of cancer care by bridging leading-edge science with compassionate, patient-centered care at the speed of life.

Click for Source

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective
OVN Avatar Meena N Murugappan, PharmD, MPH, PhD(c), Bellinda L King-Kallimanis, PhD, Gregory H Reaman, MD, Vishal Bhatnagar, MD, Erica G Horodniceanu, MPH, Najat Bouchkouj, MD, Paul G Kluetz, MD

Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective

Article
Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives
OVN Avatar Jaques van Heerden, MD, Mohamed Zaghloul, MD, Anouk Neven, MSc, Teresa de Rojas, MD, PhD, Jennifer Geel, MD, Catherine Patte, MD, Joyce Balagadde-Kambugu, MD, Peter Hesseling, MD, Francine Tchintseme, MD, Eric Bouffet, MD, and Laila Hessissen, MD

Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives

Article
Clinical development success rates and social value of pediatric Phase 1 trials in oncology
OVN Avatar Mateusz T. Wasylewski, Karolina Strzebonska, Magdalena Koperny, Maciej Polak, Jonathan Kimmelman, Marcin Waligora

Clinical development success rates and social value of pediatric Phase 1 trials in oncology

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V. Neel, David S. Shulman, Clement Ma, Florence Bourgeois, Steven G. DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps
OVN Avatar Carrie Printz

Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps

Explore OVN